Recommended Terms and Definitions From the 2025 NCCN Biomarkers Resource Committee

The NCCN Biomarkers Resource Committee (BRC) was established to provide molecular expertise and guidance related to key aspects of biomarker testing in NCCN publications. A key aim is to reduce inconsistencies and standardize biomarker testing terms and definitions for suggested use across all NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). The key areas found to need terminology clarification and harmonization included those describing types of genomic events and testing approaches. For these areas, current professional society guidelines regarding terminology, utilization within current guidelines, and common parlance in practice were explored. Synonyms were also identified. Each area was discussed to nominate preferred (and, when applicable, nonpreferred) terminology with a rationale. The aims of this document are to define commonly used terms for clinical care providers and provide recommendations for the standardized use of this biomarker terminology within NCCN Guidelines and publications.

Authors

Institutions

Publication Details

Journal
Journal of the National Comprehensive Cancer Network
Published
2026-04-27
DOI
https://doi.org/10.6004/jnccn.2026.7021
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recommended Terms and Definitions From the 2025 NCCN Biomarkers Resource Committee

Ahmet Doǧan, Tuya Pal, Marian L. Birkeland, Dara L. Aisner et al.
Journal of the National Comprehensive Cancer Network
Lung Cancer Treatments and Mutations
article

Recommended Terms and Definitions From the 2025 NCCN Biomarkers Resource Committee

Ahmet Doǧan, Tuya Pal, Marian L. Birkeland, Dara L. Aisner, Jennelle C. Hodge, Melissa Yuwono Tjota, K.A. Allison, Lawrence J. Jennings, Fei Dong, Valentina Nardi, Tamara L. Lotan, Svitlana Ostanina
article en

Abstract

The NCCN Biomarkers Resource Committee (BRC) was established to provide molecular expertise and guidance related to key aspects of biomarker testing in NCCN publications. A key aim is to reduce inconsistencies and standardize biomarker testing terms and definitions for suggested use across all NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). The key areas found to need terminology clarification and harmonization included those describing types of genomic events and testing approaches. For these areas, current professional society guidelines regarding terminology, utilization within current guidelines, and common parlance in practice were explored. Synonyms were also identified. Each area was discussed to nominate preferred (and, when applicable, nonpreferred) terminology with a rationale. The aims of this document are to define commonly used terms for clinical care providers and provide recommendations for the standardized use of this biomarker terminology within NCCN Guidelines and publications.

Journal of the National Comprehensive Cancer Network
Northwestern University (US), Indiana University Health (US), Memorial Sloan Kettering Cancer Center (US), Johns Hopkins University (US), Johns Hopkins Medicine (US), University of Chicago (US), Massachusetts General Hospital (US), Stanford Health Care (US), Indiana Cancer Consortium (US), National Comprehensive Cancer Network, University of Colorado Anschutz Medical Campus (US), Indiana University – Purdue University Indianapolis (US), Vanderbilt University Medical Center (US)
Openalex Percentile: Top 6%
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.